Explore more publications!
North Carolina Wellness News
Got News to Share?

North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 23, 2026

Calvary Placement Agency Announces Launch and Ribbon Cutting Ceremony in Charlotte, North Carolina
Feb. 23, 2026

Calvary Placement Agency Announces Launch and Ribbon Cutting Ceremony in Charlotte, North Carolina

Indeterminate EIN Presswire
AblePath ABA launches in-home ABA therapy across North Carolina to meet growing demand
Feb. 23, 2026

AblePath ABA launches in-home ABA therapy across North Carolina to meet growing demand

Indeterminate EIN Presswire
Dr. Michael Law Named Best Plastic Surgeon in Raleigh by WRAL News for Ninth Consecutive Year
Feb. 23, 2026

Dr. Michael Law Named Best Plastic Surgeon in Raleigh by WRAL News for Ninth Consecutive Year

Indeterminate EIN Presswire
UNC Nutrition Research Institute Explores Precision Nutrition Approach in Autism Study
Feb. 23, 2026

UNC Nutrition Research Institute Explores Precision Nutrition Approach in Autism Study

Indeterminate EIN Presswire
Supernus Pharmaceuticals to Participate in March Investor Conferences
Feb. 23, 2026

Supernus Pharmaceuticals to Participate in March Investor Conferences

Indeterminate GlobeNewswire
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Feb. 23, 2026

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

Indeterminate GlobeNewswire
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Feb. 23, 2026

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

Indeterminate GlobeNewswire
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Feb. 23, 2026

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations 
Feb. 23, 2026

Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations 

Indeterminate GlobeNewswire
Smith+Nephew signs distribution agreement with SI-BONE
Feb. 23, 2026

Smith+Nephew signs distribution agreement with SI-BONE

Indeterminate GlobeNewswire
Ultragenyx to Participate at Investor Conferences in March
Feb. 23, 2026

Ultragenyx to Participate at Investor Conferences in March

Indeterminate GlobeNewswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 23, 2026

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
Feb. 23, 2026

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
Silo Pharma Announces Share Buyback Program
Feb. 23, 2026

Silo Pharma Announces Share Buyback Program

Indeterminate GlobeNewswire
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Feb. 23, 2026

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Feb. 23, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

Indeterminate GlobeNewswire
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
Feb. 23, 2026

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

Indeterminate GlobeNewswire
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
Feb. 23, 2026

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Indeterminate GlobeNewswire
Sana Biotechnology to Present at March 2026 Investor Conferences
Feb. 23, 2026

Sana Biotechnology to Present at March 2026 Investor Conferences

Indeterminate GlobeNewswire
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Feb. 23, 2026

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions